...
首页> 外文期刊>Journal of Korean medical science. >Comparison of Serum Beta 2-Microglobulin and 24 hour Urinary Creatinine Clearance as a Prognostic Factor in Multiple Myeloma
【24h】

Comparison of Serum Beta 2-Microglobulin and 24 hour Urinary Creatinine Clearance as a Prognostic Factor in Multiple Myeloma

机译:血清β2-微球蛋白和24小时尿肌酐清除率作为多发性骨髓瘤预后因素的比较

获取原文
           

摘要

A new staging system for multiple myeloma (MM) has utilized serum concentrations of beta 2-microglobulin (Sβ2M) and albumin as important prognostic factors for survival. Since Sβ2M is an indicator of glomerular filtration rate, we compared the prognostic values of Sβ2M and 24-hr urinary creatinine clearance (Ccr) in patients with MM. We retrospectively reviewed the records of 170 MM patients from January 1996 to November 2003 whose 24-hr urinary Ccr was available at the time of diagnosis. We found that pretreatment Sβ2M was inversely related to Ccr (Spearman's correlation coefficient=-0.787). In univariate analysis, the hazard ratio (HR) of death was 1.043 ( p 2M and 0.985 ( p 2M (HR 1.030, p =0.010) and Ccr (HR 0.993, p =0.059) were significant prognostic factors in patients' survival. In conclusion, 24-hr urinary Ccr may be utilized for staging of patients with MM.
机译:一种针对多发性骨髓瘤(MM)的新分期系统已经利用血清β2-微球蛋白(Sβ 2 M)和白蛋白的浓度作为生存的重要预后因素。由于Sβ 2 M是肾小球滤过率的指标,因此我们比较了MM患者中Sβ 2 M和24小时尿肌酐清除率(Ccr)的预后价值。我们回顾性研究了1996年1月至2003年11月期间170例MM患者的记录,这些患者在诊断时可获得24小时尿Ccr。我们发现,预处理Sβ 2 M与Ccr成反比(Spearman相关系数= -0.787)。在单因素分析中,死亡的危险比(HR)为1.043(p 2 M和0.985(p 2 M(HR 1.030,p = 0.010)和Ccr(HR 0.993,p = 0.059)是影响患者生存的重要预后因素,因此,总结24小时尿Ccr可用于MM患者的分期。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号